Takeda Pharmaceutical Company Limited (TAK)
NYSE: TAK · Real-Time Price · USD
19.45
+0.44 (2.31%)
At close: Oct 15, 2026, 4:00 PM EDT
19.47
+0.02 (0.10%)
After-hours: Oct 15, 2026, 7:45 PM EDT
Takeda Pharmaceutical Market Cap
Takeda Pharmaceutical has a market cap or net worth of $62.43 billion as of October 15, 2026. Its market cap has increased by 44.82% in one year.
Market Cap
62.43B
Enterprise Value
94.54B
1-Year Change
44.82%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since January 5, 2010, Takeda Pharmaceutical's market cap has decreased from $71.21B to $62.43B, a decrease of -12.32%. That is a compound annual growth rate of -0.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 62.43B | 28.19% |
| Dec 31, 2025 | 48.70B | 15.61% |
| Dec 31, 2024 | 42.13B | -5.91% |
| Dec 29, 2023 | 44.78B | -7.43% |
| Dec 30, 2022 | 48.37B | 13.50% |
| Dec 31, 2021 | 42.62B | -24.84% |
| Dec 31, 2020 | 56.70B | -8.18% |
| Dec 31, 2019 | 61.76B | 134.31% |
| Dec 31, 2018 | 26.36B | -59.21% |
| Dec 30, 2016 | 64.61B | -22.54% |
| Dec 31, 2015 | 83.40B | 20.68% |
| Dec 31, 2014 | 69.11B | -9.90% |
| Dec 31, 2013 | 76.71B | 3.69% |
| Dec 31, 2012 | 73.97B | 0.68% |
| Dec 30, 2011 | 73.47B | -9.45% |
| Dec 31, 2010 | 81.14B | 13.94% |
| Jan 5, 2010 | 71.21B | - |
View and export this data all the way back to 2010. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 48.41B |
| Haleon | 43.29B |
| Zoetis | 32.34B |
| United Therapeutics | 23.49B |
| Viatris | 20.82B |
| Neurocrine Biosciences | 13.92B |
| Elanco Animal Health | 11.71B |
| Dr. Reddy's Laboratories | 10.84B |